Northfield Laboratories Presentation at the SG Cowen & Company Global Health Care Conference to Be Webcast Live

EVANSTON, Ill., Nov. 2  /PRNewswire-FirstCall/ -- Northfield Laboratories Inc. (NASDAQ:NFLD) announced today that Steven A. Gould, M.D., Chairman and Chief Executive Officer, will be presenting at the SG Cowen & Company Global Health Care Conference in Barcelona, Spain, on Wednesday, November 9, 2005, at 8:35 a.m. local time, 2:35 a.m. E.T.

Interested investors may access the live webcast of the presentation at http://www.northfieldlabs.com/ .  A replay of the presentation will be available and will be archived for two weeks.

About Northfield Laboratories

Northfield Laboratories Inc. is a leader in developing an oxygen-carrying resuscitative fluid, PolyHeme(R), for the treatment of urgent, large volume blood loss in trauma and resultant surgical settings.  PolyHeme(R) is a solution of chemically modified human hemoglobin that requires no cross matching and is therefore compatible with all blood types.  It has a shelf life of over 12 months.  Enrollment is currently underway in a pivotal Phase III trial of PolyHeme(R) beginning in the pre-hospital setting. For further information, visit http://www.northfieldlabs.com/ .

  FOR FURTHER INFORMATION CONTACT:

                                            Sharon L. Weinstein
  Sophia H. Twaddell                        Director, Investor Relations
  Vice President, Corporate Communications  Noonan Russo
  [phone]                            [phone]
                

DATASOURCE: Northfield Laboratories Inc.



CONTACT:  Sophia H. Twaddell, Vice President, Corporate Communications,

of Northfield Laboratories Inc., [phone],

; or Sharon L. Weinstein, Director, Investor

Relations, of Noonan Russo, [phone], 



Web site:  http://www.northfieldlabs.com/ 

Copyright